Skip to main content
nl
fr
en
Get to know Sciensano
About Sciensano
Sciensano in figures
Sciensano's structure
Contact Sciensano
Our commitment to quality, health, safety and environment
Our commitment to collecting and managing data
Partnerships
Emergency and Response
Working / doing an internship at Sciensano
Jobs
Values and standards
History of Sciensano
2023 Annual report
Donations and bequests
Areas of expertise
List of health topics from A-Z
Health and disease monitoring
Animal Health
Effectiveness of safety of vaccines, medicines and health products - Quality of medical laboratories
Food consumption and food safety
Health and environment
Quality of healthcare
Our services
Analysis request
Data collection
External quality assessment
Control and Safety Assessment
Licensing
Health Information
Health Threats
Projects
Reports & Publications
Press Corner
Search form
Search
Home
Send a question to our expert about Post-authorisation surveillance of COVID-19 vaccines
Send a question to our expert about Post-authorisation surveillance of COVID-19 vaccines
Joris Van Loenhout
Scientist
You must have JavaScript enabled to use this form.
Your question
*
Your name
*
How do you want to be contacted ?
By E-mail ?
By phone (during office hours) ?
Leave this field blank
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Send
Contacts
Epidemiology of infectious diseases
Izaak Van Evercooren
Elias Vermeiren
Joris Van Loenhout
Veerle Stouten
Pierre Hubin
Amber Litzroth
Healthcare-associated infections and antimicrobial resistance
Lucy Catteau
Peer-reviewed publications
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.
Events
In the media
Other publications
Is equitable priority vaccination of the vulnerable feasible in a real-world context? The case of Belgium
Estimated number of COVID-19 deaths averted by vaccination in Belgium
Draft implementation plan for a linkage tool
An interdisciplinary approach: Exploring the five dimensions of the tools deployed by EUVABECO
Surveillance van de COVID-19 vaccinatie in Belgische woonzorgcentra. Resultaten tot 24 maart 2021.
Other sources of information
QR code
